Geogard Ultra: A New Alternative Cosmetic Preservative

---

Pressemitteilung

- - - - - - - - - - START HELP.CH - PRESSEMITTEILUNG - - - - - - - - - -

28.10.2005, Lonza announces the launch of Geogard® Ultra, a new product to meet the growing demand for alternative cosmetic preservatives.

With growing concerns over traditional preservatives such as parabens, Geogard® Ultra provides a single solution to companies seeking alternatives to traditional preservatives. Geogard® Ultra’s global regulatory acceptance, broad-spectrum activity and multifunctionality means it can be utilized in a wide variety of cosmetic products like shampoos, lotions and skin creams. Unlike traditional cosmetic preservatives, Geogard® Ultra can be used in cosmetic products that are marketed in major markets around the world: Europe, Japan, North America and South America.

Geogard® Ultra helps prevent product spoilage by utilizing less aggressive: “Hurdle Technology.” Instead of a harsh, aggressive approach with bacteria and fungi, Geogard® Ultra primarily functions by creating a more hostile environment within the formulation for microbes to overcome. Potentiators within Geogard® Ultra help create such hurdles, increasing the self-preserving environment of formulations.

Geogard® Ultra also provides greater utility with its multifunctional action. Geogard® Ultra not only provides effective protection against product spoilage, but it can also increase the skin moisturizing capacity of the formulation.

Geogard® Ultra represents a new approach to multifunctional specialties for the personal care market. The first in a new platform of products with such multifunc-tionality, Geogard® Ultra is indicative of Lonza’s efforts to find innovative solutions that address today’s preservation and related formulator needs.

Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.18 billion in 2004. Headquartered in Switzerland, Lonza operates 18 production and R&D sites around the world. Its 5700 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the lead-ing custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of or-ganic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds.

In the Personal Care industry, Lonza is one of the world’s leading specialty chemical companies with substantial global resources in research and development, technical and applications service and broadly based manufacturing capability. Lonza has an on-going commitment to developing technology and solutions to the Personal Care industry in a variety of areas including world-leading positions in preservatives and specialty active compounds. For more information please visit the company's websites at www.lonza.com or www.lonzabiocides.com.

For further information please contact:

Carl Cappabianca Vice President of Personal Care Global Marketing Lonza Inc. Tel +1 201 316 9305 Fax +1 201 785 9013 carl.cappabianca@lonza.com

Christine Casper Communications Manager Lonza Inc. Tel +1 201 316 9236 Fax +1 201 785 9013 christine.casper@lonza.com

Über Lonza Group AG

Lonza zählt zu den weltweit führenden Anbietern von Produkten und Dienstleistungen für die Pharma, Gesundheits und Life Sciences-Industrien und ist in der Lage, ihre Kunden vom Forschungsstadium bis hin zur Endproduktion mit ihren Lösungen zu begleiten.

Lonza ist Weltmarktführer in der Produktion und Prozessbegleitung von pharmazeutischen Wirkstoffen, sowohl im chemischen als auch im biotechnologischen Bereich. Biopharmazeutika gehören zu den wichtigsten Wachstumsmotoren der Pharma- und Biotechnologieindustrie.

Lonza verfügt über ausgezeichnetes Know-how in der Herstellung von grossen und kleinen Molekülen, Peptiden, Aminosäuren und in der Nischenproduktion von Bioprodukten, die eine wichtige Rolle bei der Entwicklung neuartiger Arzneimittel und Gesundheitsprodukte spielen. Lonza ist führend in zellbasierter Forschung, in endotoxinen Nachweissystemen sowie in der Zelltherapieproduktion.

Lonza ist ebenfalls eine führende Anbieterin hochwertiger chemischer und biotechnologischer Zwischenprodukte für die Märkte Ernährung, Hygiene, Wasser- und Holzbehandlung, Agro und Körperpflege.

Lonza hat ihren Hauptsitz in Basel, Schweiz, und ist an der SWX Swiss Exchange notiert. Lonza erzielte im Jahr 2006 einen Umsatz von CHF 2,91 Milliarden.

Quelle:



- ENDE HELP.CH - PRESSEMITTEILUNG Geogard Ultra: A New Alternative Cosmetic Preservative -

Publiziert am 28.10.05

---

Die Pressemitteilung Geogard Ultra: A New Alternative Cosmetic Preservative wurde publiziert am 28.10.2005 (Achtundzwanzigster Oktober). Die Meldung Geogard Ultra: A New Alternative Cosmetic Preservative hat die ID News-HLP-26-13267.

---

Weitere Informationen und Links:

	Lonza Group AG (Firmenporträt)
	Artikel 'Geogard Ultra: A New Alternative Cosmetic ...' auf Swiss-Press.com